CANCER OF THE PANCREAS
Clinical trials for CANCER OF THE PANCREAS explained in plain language.
Never miss a new study
Get alerted when new CANCER OF THE PANCREAS trials appear
Sign up with your email to follow new studies for CANCER OF THE PANCREAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to boost chemo for tough pancreatic cancer
Disease control Recruiting nowThis early-phase trial tests whether adding an experimental MK2 inhibitor (zunsemetinib) to standard chemotherapy (mFOLFIRINOX) can better control metastatic pancreatic cancer. About 51 adults who have not had prior treatment for advanced disease will participate. The main goals …
Matched conditions: CANCER OF THE PANCREAS
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New combo therapy aims to slow advanced pancreatic cancer
Disease control Recruiting nowThis phase 2 trial tests whether adding two drugs (defactinib and avutometinib) to targeted radiation therapy can help people with advanced pancreatic cancer live longer without their cancer growing. About 36 participants with borderline resectable or locally advanced pancreatic …
Matched conditions: CANCER OF THE PANCREAS
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Scientists track Cancer's inner workings during radiation treatment
Knowledge-focused Recruiting nowThis study is for people with cervical or pancreatic cancer who are scheduled to receive chemoradiotherapy. Researchers will collect tumor samples, blood, and imaging data before, during, and after treatment to see how the tumor environment changes over time. The goal is to learn…
Matched conditions: CANCER OF THE PANCREAS
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC